7 Wholesale Soybean Milk Machine Websites For Wholesaler
7 Wholesale Soybean Milk Machine Websites For Wholesaler

With the emphasis on health gradually strengthened. In order to clean and health, a lot of families have chosen to make soy milk, thus driving home microcomputer automatic soybean milk machine market. Soybean milk has high nutritional value and is an ideal healthy food. According to expert introduction, contain a variety of high grade protein, a variety of vitamins, a variety of human body to need amino acid and a variety of microelement to wait in soya-bean milk. Whether adults, the elderly or children, as long as the consistent drinking, to improve the constitution, immunity, prevention and treatment of disease, there are great benefits. This article mainly introduces what a good soybean milk machine looks like, and lists 7 high-quality websites of wholesale soybean milk machine. If it's exactly what you need, please read on. The market of soybean milk machineIn recent years, household soybean milk machine market demand has shown the momentum of accelerated growth. Domestic soybean milk machine market sales from 2005 to 2007 were 2.5 million, 3 million, 5 million respectively, this year's sales are expected to soar to 10 million. Experts expect the soybean milk machine market to be very optimistic in the coming years. Compared with other products, small home appliances profit is high, more than 30 percent, so now many enterprises have increased the investment in small home appliances, such as philips, TCL, the United States. In addition, the development speed of this market is also very fast, including soybean milk machine whole small home appliance market in the next few years will usher in a huge space for development. Broad foreground also drew the covet of numerous home appliance enterprise naturally, the soybean milk machine brand on the market is numerous enumerate, but it is a big situation alone for a long time, jiuyang is holding the market of the left and right sides with the advantage of forerunner and abundant actual strength, have absolute monopoly position. Until recently, things seemed to be improving, with midea announcing a strong entry into the soybean milk machine market. Soybean milk machine industry has developed rapidly in the past two years, and the market prospect is very broad. At present, the highly monopolized structure of the industry also needs to be broken, which is the main reason for many people entering soybean milk machine industry. Wholesale WebsitesEn.china.cnEn.China.cn is one of the best B2B websites in China. En.China.cn was founded in 2006. During the 13 years of steady development, the platform has accumulated tens of millions of suppliers and buyers. Many people visit this website every day and find satisfactory products on this website. If you want to wholesale soybean milk machine, this site is definitely worth a look. He has the following advantages: 1. Fast delivery. Most suppliers promise to ship within 15 days, and some can ship within 7 days. If you are in a hurry, you can get your soybean milk machine here as soon as possible.2. Payment method is convenient and quick. En.China.cn supports more than ten payment methods. You can browse the products anytime, anywhere, and decide the products you want to buy quickly and conveniently. And, with just one button, you can get in touch with the supplier.3. High security. Because En.China.cn is a state-backed platform and they've been around for 13 years, their system is highly secure and your privacy will never be compromised. Also, the network that the supplier must be real, you can feel free to buy your goods.  Sejal enterpriseThe company was established in 1999, is a set of pipe fittings, machinery, generators, lubrication equipment and pumps manufacturing, supply, import and trade as one of the well-known enterprises. Headquartered in pune (maharashtra), India, they have been wholly owned since their establishment. The machines produced by the company are featured by strong function, excellent performance, high dimensional accuracy, high tensile strength, low maintenance cost, good wear resistance, strong structure, strong design and long service life. Because of these characteristics, their products are widely used in agriculture, family, medicine and industry.  Global SourceThe Global Source catalog is dominated by large factories and trading companies. This is because of their policy of valuing quality materials and services. While smaller businesses and companies can get into their directories, they need more capital. These larger companies and factories are able to sell their products to buyers in a large wholesale market.Global source provides bulk products, not individual products. Because of their policy, these larger factories sell their products in bulk at wholesale prices. This makes the overall price of each product cheaper. These products are not as profitable as shipping them directly from factories and warehouses. This means you can save even more money when you order in bulk from global suppliers.Be sure to ask the supplier in advance if the product is in stock and how soon it can be delivered. ArkartechArkartech is another Chinese wholesale website that outsources its inventory. They do have their own inventory and not rather depend on vendors to bring in their own inventory. This is why many smaller businesses are present on the Arkartech. You can easily find many items of different categories from both small vendors and medium-sized vendors. AlibabaAlibaba has several large businesses, several small businesses, and even some suppliers who work from home. This diversity and large number of suppliers can be on the site, which can be confusing because they do not all offer the same quality of services and materials.However, a general rule of thumb is to use the product review section as well as the vendor to determine if the purchase is worth it. You must be careful to select real reviews, not paid or fake ones, which may have been fabricated by vendors to make their profile look more attractive. DhgateDHgate has no minimum requirements to make it easier for buyers. Buyers can buy only one or two items. Many wholesale suppliers offer discounts for wholesale projects. So, if you increase your quantity, the supplier will probably give you a discount. That means the more you buy, the lower the price.  Yiwu goYiwu go provides an opportunity for small and medium-sized enterprises to sell goods. You will find several kinds of yiwu Go, from which you can choose the product you want.Most of these products come from domestic Chinese companies. Most suppliers come from yiwu international trade city. This means that these suppliers may have their own factories and workshops where they produce their own products. Techniques of choose and buy1. It is to understand the source of materials and accessories used. Soybean milk machine generally USES better materials and accessories, and there are some imported accessories. 2. Check the power plug and wire, etc., and buy products certified by national quality and safety system, such as 3C certification and the Europe Union CE certification. The soybean milk machine that sells in the market must accord with the requirement of national safety standard, must carry CCC attests mark, but the product that sells in a few markets still did not pass CCC attests now, you must recognize and hold. 3. Perfect service system is a good guarantee of product quality, so there should be pre-sale, in-sale and post-sale services as well as network density to meet the service requirements. 4. Crushing effect: whether the performance of the motor and the design of the blade are reasonable determines the degree of bean crushing and the level of pulp yield. 5. Technology of mesh cover: good mesh cover mesh according to the herringbone cross arrangement, dense and uniform. 6. Look at the shape of the heating tube: the lower half of the ideal soybean milk machine heating tube is a small semicircle, easy to wash and load and unload the mesh cover. 7. See whether to use the "golden ratio" design: the ratio of the amount of beans to the amount of water, the water temperature of the grinding, the grinding time, the cooking time and other factors ConclusionThere are many types of soybean milk machine and you need to carefully select the brand you are satisfied according to the purchasing techniques mentioned in this article. Finally, make sure the buyer gives you a discount before you buy, and you'll often get more surprises.

Wholesale Suppliers 2554 51 11/25/19
Show
12|
20|
28
  • Go

RECENT POSTS

German manufacturer Karcher opens regional distribution centre at Tatu City, Kenya
German manufacturer Karcher opens regional distribution centre at Tatu City, Kenya

Brings a wide range of innovative products aiming to become the market leader for cleaning solutions in East Africa TATU CITY, Kenya, March 28, 2024 /PRNewswire/ -- German-based cleaning equipment manufacturer Karcher has announced an approximate €3 million investment in the Kenyan market. The move was made to operationalize the business into a full subsidiary, which includes a regional distribution centre at Freight Forwarders Solutions (FFS) in Tatu City, the 5,000-acre mixed-use Special Economic Zone (SEZ) on Nairobi's doorstep, positioning Kenya as a hub for East Africa. L-R: Axel Stolz, Regional President, Africa & India, Karcher; Richard Mumo, Managing Director Kenya & General Manager, East Africa, Karcher; Christian May, Deputy Chief Executive Officer & Chief Sales Officer, Karcher; Mr. Sebastian Groth, Ambassador of the Federal Republic of Germany to Kenya; and Joseph Nguyo, Senior Deputy Secretary, State Department for Investment Promotion during the official launch of Karcher’s local warehouse operations at Tatu City Christian May, Deputy Chief Executive Officer and Chief Sales Officer at Karcher, emphasized the importance of this investment: "Our goal is to transform the cleaning landscape in Kenya by bringing advanced products and services to our customers. By establishing Kenya as our regional hub, we are reducing lead times and enhancing responsiveness, ensuring prompt service and satisfaction for our clients." Stephen Jennings, Founder & CEO of Rendeavour, the owner and developer of Tatu City, added, "Karcher joins the ranks of many leading global brands at Tatu City SEZ. As Kenya's first mixed-used SEZ, Tatu City has already attracted USD 2.5 billion in investment from more than 78 businesses, from healthcare and food and beverage production to call centres, software engineering, and now cleaning solutions. These investments are creating many thousands of much-needed jobs for Kenyans." The company that provides warehouse operations for Karcher in Kenya, FFS, has an international-standard logistics and distribution hub in Tatu Industrial Park. FFS provides inbound cargo, freight, and transport services across East and Central Africa. It has a 14,000 m2 warehouse complex, equivalent to the size of some of Nairobi's larger shopping malls, at Africa Logistics Properties (ALP), in Tatu City. FFS CEO Ben Clay said, "As we launch warehouse operations for Karcher in the Kenyan market, we are committed to empowering businesses with seamless logistics solutions, leveraging technology, and fostering excellence in service delivery and economic growth." "Karcher's investment in Kenya highlights the strong economic ties between Germany and Kenya. As a global leader in cleaning technology, Karcher exemplifies German engineering excellence and innovation. We look forward to further collaboration and mutual growth between our two nations," said Sebastian Groth, Ambassador of the Republic of Germany to Kenya. Karcher has established a presence in seven Carrefour outlets and partnered with various distributors to cater to different customer segments. Its flagship store, located in Upper Hill, Nairobi, serves as a brand store and service centre operated by Equipment and Logistics Limited, which was recently presented with a twenty-year partnership award. More than 78 local, regional and global businesses are operational or under development in Tatu City's business-friendly location, including CCI Global, Heineken, Dormans, Copia, Cooper K-Brands, Grit Real Estate Income Group, Twiga Foods, Freight Forwarders Solutions, ADvTECH, Friendship Group and Davis & Shirtliff. Business benefits at Tatu City SEZ include VAT zero-rating, import and stamp duty exemptions and 10% corporate tax for the first 10 years and 15% for 10 years thereafter. About Tatu City (www.tatucity.com) Tatu City is a 5,000-acre new city on Nairobi's doorstep with homes, schools, businesses, a shopping district, medical clinic, nature areas and recreation for more than 250,000 residents and tens of thousands of day visitors. Tatu City's schools educate thousands of students daily, a range of homes suits all incomes and more than 78 businesses thrive in the country's first operational Special Economic Zone. Located 30 minutes from Westlands, Tatu City represents a new way of living and thinking for all Kenyans in a live, work and play environment that is free from traffic congestion and long-distance commuting. Tatu City is a development by Rendeavour, Africa's largest new city builder with 30,000 acres of visionary projects in growth trajectories across Ghana, Nigeria, Kenya, Zambia and the Democratic Republic of Congo. About Karcher (https://www.karcher.com/ke/) Kärcher is a globally active family-owned company from Winnenden and the world market leader in cleaning technology. Karcher is a B2B and B2C global brand known for its high-pressure cleaners, floor care equipment, parts cleaning systems, wash water treatment, military decontamination equipment and window vacuum cleaners, among others.  

ACE Money Transfer and Bank AL Habib Partner Again to Empower Overseas Pakistanis and Strengthen Pakistan's Economy this Ramadan
ACE Money Transfer and Bank AL Habib Partner Again to Empower Overseas Pakistanis and Strengthen Pakistan's Economy this Ramadan

MANCHESTER, England, March 27, 2024 /PRNewswire/ -- ACE Money Transfer, a leading remittance provider headquartered in Manchester, UK, and Bank AL Habib, one of Pakistan's premier commercial banks, have joined forces once again to incentivize overseas Pakistanis to send money home through legal channels while offering them the chance to win substantial rewards. 25 Umrah packages are being offered, allowing winners to undertake the sacred pilgrimage during the holy month. The grand prize - Two lucky winners will each receive a rupees 1 crore cash prize. The Importance of Legal Remittances Legal remittances contribute significantly to Pakistan's foreign exchange reserves, aiding in economic growth and stability. Conversely, informal channels for sending money can be unreliable and pose security risks. Remittances are a vital lifeline for Pakistan's economy, and by incentivizing legal transfers through such rewards during Ramadan, ACE Money Transfer and Bank AL Habib play a key role in supporting national development and ensuring the well-being of many families. How to Participate? The process is simple. The remitter is required to send money to Pakistan via ACE Money Transfer's app or website from the UK, Europe, Canada, or Australia to any Bank AL Habib account or choose cash pickup from one of Bank AL Habib's 1100+ branches in Pakistan and use the promo code "UMRAH" when creating the transaction. The offer is valid during the month of Ramadan, 2024. Mr. Rashid Ashraf, CEO of ACE Money Transfer, stated, "This collaborative effort transcends mere transactions. It acknowledges the profound significance of Ramadan, a time for spiritual reflection, generosity, and strengthening family bonds. We at ACE Money Transfer are proud to revitalize our longstanding partnership with Bank AL Habib and offer such incredible opportunities to overseas Pakistanis while contributing to Pakistan's economic well-being." Mr. Aun Ali, Group Head – Business of Bank AL Habib, said, we are excited to announce the launch of the media campaign in collaboration with ACE Money transfer during the holy month of Ramadan. The campaign shows our commitment to building a meaningful relationship with our customers and encouraging them to use legal channels to send money to Pakistan. Ali Zafar, the campaign ambassador, shared his thoughts: "I am honored to be associated with this initiative. During Ramadan, the spirit of giving is at its peak, and these contributions must reach their intended recipients safely and securely. By using legal channels like ACE Money Transfer and Bank AL Habib, overseas Pakistanis can ensure their hard-earned money makes a real difference back home while strengthening Pakistan's economy." Website: http://www.acemoneytransfer.com/    

Ascentage Pharma Announces 2023 Annual Results
Ascentage Pharma Announces 2023 Annual Results

SUZHOU, China and ROCKVILLE, Md., March 27, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its annual results for the full year 2023. During the reporting period, Ascentage Pharma made further strides in revenue generation through its commercialized product, achieved rapid progress with its patient-centric global innovation strategy, and delivered numerous milestones in clinical development and global expansion. Newly approved indication of olverembatinib expands the drug's addressable market In 2023, Ascentage Pharma recorded a revenue of RMB222 million, most of which was attributable to product sales and milestone payments, including a revenue of RMB194 million from product sales. For the first time, the company achieved commercial breakeven through topline growth while keeping selling and distribution expenses at a manageable level and significantly improving the efficiency of marketing activities. Developed internally by Ascentage Pharma, olverembatinib is the first and only approved third-generation BCR-ABL inhibitor in China. In January 2023, as a Model Product of China-Developed Innovative Drugs, olverembatinib was included into the 2022 National Reimbursement Drug List (NRDL), a major step-forward that drastically improved the drug's accessibility and paved the way for accelerated volume growth. Since its approval till December 31, 2023, olverembatinib generated an accumulated sales revenue of RMB362 million (audited, inclusive of value-added tax).  Meanwhile, Ascentage Pharma continued to strengthen its ability to drive revenue growth through product commercialization. On November 17, 2023, olverembatinib was approved for adult patients with chronic-phase chronic myeloid leukemia (CML-CP) resistant and/or intolerant of first-and second-generation tyrosine kinase inhibitors (TKIs). The indication expansion will allow a broader population of patients with CML to benefit from the drug and offer a new treatment option to drug-resistant patients, which will further olverembatinib's commercial success. During the reporting period, the sales volume of olverembatinib increased 259%, the number of listed hospitals increased 567%, the total number of patients on treatment increased 123%. Looking ahead in 2024, with the approval of the new indication of olverembatinib, compounded by accelerated hospital listings, a growing number of patients on treatment, and ever longer duration of treatment, more patients will benefit from olverembatinib, driving the sales of the product. Obtained clearances for five global registrational Phase III trials as the global innovation strategy began to bear fruit Led by its global innovation strategy, Ascentage Pharma has delivered multiple milestones in clinical development as it effectively advanced global clinical development programs. Since the beginning of 2023, olverembatinib and the Bcl-2 inhibitor lisaftoclax (APG-2575) have been cleared to commence five global registrational Phase III studies, bolstering the company's moat in the field of hematologic malignancies. In February 2024, the US Food and Drug Administration (FDA) cleared a global registrational Phase III trial of olverembatinib in previously treated adult patients with CML-CP. This is the first global registrational Phase III trial of olverembatinib cleared by the US FDA and represents another step in Ascentage Phara's growing presence in the global hematology arena. In January 2024, as a global best-in-class innovative drug from China, olverembatinib was included in the National Comprehensive Cancer Network (NCCN)'s latest guidelines for the management of CML. This inclusion highlights the therapeutic utility of olverembatinib and marks another major recognition from the global oncology community. In addition to CML, olverembatinib has also made significant progress with its clinical development for the treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). In July 2023, the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) granted the clearance for the global registrational Phase III trial of olverembatinib in combination with chemotherapy versus imatinib in combination with chemotherapy for the treatment of newly diagnosed patients with Ph+ ALL, paving the way for olverembatinib to potentially become the first China-approved TKI for the treatment of patients with Ph+ ALL in the first-line setting. Lisaftoclax obtained clearances for three global registrational Phase III studies. In August 2023, the US FDA cleared a global registrational Phase III study of lisaftoclax in previously treated patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). This regulatory clearance marked a major step-forward in the global clinical development of lisaftoclax as it can potentially accelerate the drug's journey to market as the world's second approved Bcl-2 inhibitor competing in the global market. Shortly after receiving this clearance, lisaftoclax was approved by the China CDE to enter a global registrational Phase III study of lisaftoclax combined with acalabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, versus immunochemotherapy for the first-line treatment of patients with CLL/SLL. In December 2023, the China CDE approved another global registrational Phase III study of lisaftoclax for the first-line treatment of newly diagnosed elderly or unfit patients with acute myeloid leukemia (AML). Promising clinical results underscore strong competitiveness in the field of hematologic malignancies Pursuing its mission of addressing unmet clinical needs in China and around the world, Ascentage Pharma has built a rich pipeline composed of promising drug candidates with first-in-class and/or best-in-class potentials, and is conducting more than 40 clinical studies in China, the US, Australia, Europe, and Canada. The company's innovative and clinical development capabilities have received growing recognition from the global research community as it continued to explore and validate the therapeutic potential of its drug candidates and frequently showcased new clinical data at major international congresses. At the 65th American Society of Hematology (ASH 2023), Ascentage Pharma presented the latest results from multiple studies of olverembatinib and lisaftoclax, demonstrating the clinical advantages of these products. Among those studies, two studies of olverembatinib were selected for Oral Presentations, making 2023 the sixth consecutive year in which data of olverembatinib were selected for Oral Presentations at the ASH Annual Meeting. One of these Oral Presentations featured a registrational Phase II study evaluating the efficacy and safety of olverembatinib versus the best available therapy (BAT) in patients with CML-CP resistant and/or intolerant to prior treatment with TKIs. Results of the study showed that compared to the BAT, olverembatinib significantly improved the prognosis of patients with CML. The other Oral Presentation featured the preliminary results from a Phase II study of olverembatinib. Selected for "Highlights of ASH", these results showed encouraging clinical benefit and favorable tolerability of an olverembatinib regimen that could potentially usher in an era of chemotherapy-free treatment for Ph+ ALL. After releasing preliminary results from the US study of olverembatinib in an Oral Report at the ASH Annual Meeting in 2022, at ASH 2023, Ascentage Pharma presented updated data from a larger patient sample that showed the favorable clinical benefit and tolerability of olverembatinib, as a monotherapy and in combinations, in heavily pretreated patients with CML or Ph+ ALL, particularly those who have failed prior treatment with the third-generation TKI ponatinib or the allosteric STAMP inhibitor asciminib. These results suggest that olverembatinib has global best-in-class potential as an effective new therapy for patients with CML or Ph+ ALL. Also at the 2023 ASH Annual Meeting, Ascentage Pharma released results from three clinical studies of lisaftoclax, for the treatment of CLL, AML, and multiple myeloma (MM), separately. Among them, the study in patients with relapsed/refractory (R/R) CLL once again showed the favorable tolerability and significant efficacy of lisaftoclax. In particular, the company released the first dataset of lisaftoclax in MM and AML that reaffirmed the global best-in-class potential and unique therapeutic utility of lisaftoclax and provided strong evidence of the drug's therapeutic applications to indications beyond CLL. Prior to that, Ascentage Pharma presented updated clinical data of olverembatinib, lisaftoclax, the MDM2-p53 inhibitor alrizomadlin (APG-115), and the FAK/ALK/ROS1 inhibitor APG-2449, four of the company's lead drug candidates, at the 59th American Society of Clinical Oncology Annual Meeting (ASCO 2023). In particular, the data of olverembatinib showed promising clinical benefit and favorable tolerability in patients with TKI-resistant succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumor (GIST), thus indicating a potential breakthrough for an indication that currently has no effective treatment. Also in 2023, olverembatinib was granted a Breakthrough Therapy Designation (BTD) by the China CDE for the treatment of patients with SDH-deficient GIST who had received first-line treatment. Building vertically integrated industrialization capabilities to further accelerate global expansion Upholding its global innovation strategy, Ascentage Pharma is committed to building a large portfolio of global intellectual property rights. As of December 31, 2023, Ascentage Pharma holds 498 issued patents globally, among which 352 patents were issued overseas. In addition, Ascentage Pharma received a zero-deficiency report from the Good Manufacturing Practice (GMP) compliance audit by a Qualified Person (QP) of the European Union (EU) in April 2023, which indicates that the company's Global Manufacturing Center and its quality management system are now fully compliant with the GMP standards of the EU, generating extra tailwind to Ascentage Pharma's ongoing transition towards a global biopharmaceutical company. "In 2023, Ascentage Pharma has achieved multiple milestones across product commercialization, global clinical development, and corporate development, while continuing to showcase its prowess in global innovation," said Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma. "The NRDL inclusion and newly approved indication of olverembatinib has further boosted the company's commercialization capabilities. Meanwhile, olverembatinib, supported by its excellent efficacy and safety, was reaffirmed as a best-in-class drug and begun to show encouraging therapeutic value in additional indications that currently have no treatment options." Dr. Yang continued, "In the past year, we accelerated our global clinical development programs and have in the process obtained clearances, including two from FDA, for five global registrational Phase III trials of olverembatinib and lisaftoclax. At the same time, our lead drug candidates continued to show clinical potential in additional indications, thus further strengthening our position in the field of hematologic malignancies." In conclusion, Dr. Yang said, "Implementing our global innovation strategy with a patient-centric approach, we have built a rich pipeline that holds enormous clinical potential, particularly in hematologic malignancies. Moving forward, we will further enhance our commercialization and clinical development capabilities, and accelerate our global clinical development programs. Fulfilling the mission of addressing unmet clinical needs in China and around the world, we aim to bring our innovative drugs to the global market in the future for the benefit more patients around the world and create greater value for our communities and shareholders."

AliExpress becomes the first exclusive e-commerce partner of UEFA EURO 2024™
AliExpress becomes the first exclusive e-commerce partner of UEFA EURO 2024™

AliExpress is investing millions of Euros in discounts, deals and engagement to connect online consumers with the fantastic game of football this summer BERLIN, March 27, 2024 /PRNewswire/ -- International online retail marketplace, AliExpress, has become the first e-commerce platform as an exclusive official global sponsor of UEFA EURO 2024TM, as the world looks ahead to an unforgettable summer with the UEFA EURO 2024™ in Germany. (From left to right) Valentina Maceri, event host; Oliver Bierhoff, Football Legend & Entrepreneur Global Sports Business; Gary Topp, European Commercial Director, AliExpress; Guy-Laurent Epstein, Marketing Director, UEFA celebrate the partnership AliExpress x UEFA EURO 2024™ AliExpress is investing millions of Euros in discounts, deals and engagement during UEFA EURO 2024™, offering shoppers a combination of discounted prices in key categories, plus exciting interactive games and chances to win time-limited prizes, including match tickets. This is part of AliExpress' increased investment in Europe. Investing millions of Euros to reward consumers during UEFA EURO 2024™ AliExpress is committed to connecting with global consumers, supporting them, so they can support their team during UEFA EURO 2024™. "AliExpress is excited to be an official partner of UEFA EURO 2024™. As football enthusiasm spreads across Europe, we will bring fans even closer to the action, with great deals on a vast selection of popular and trending products, as well as interactive games and the chance to win fantastic prizes," said Gary Topp, European Commercial Director, AliExpress. UEFA marketing director, Guy-Laurent Epstein commented: "We are thrilled to welcome AliExpress, one of the leading online retail marketplaces worldwide, as the first exclusive e-commerce platform partner for a UEFA Men's European Football Championship. We will work closely together to make the fan digital experience for this summer's spectacle as exciting as possible, bringing further innovations to football fans all around the world. This starts with offering fans the chance to win some unforgettable prizes, including match tickets for UEFA EURO 2024™." Oliver Bierhoff, Football Legend & Entrepreneur Global Sports Business, who joined AliExpress and UEFA at the announcement of the partnership, said: "Football is a truly global game that brings people together from around the world. It is great news for football to have another fan supporting this year's tournament, with the announcement of AliExpress as a proud new sponsor." Growing active consumer base AliExpress order volumes have grown significantly year-on-year, driven by "AliExpress Choice" – the platform's premium shopping service launched in March 2023, offering free shipping*, fast delivery and easy returns, on a wide selection of great value products. AliExpress customers have embraced the Choice shopping experience. Choice now accounts for almost half of all orders on AliExpress worldwide and continues to gain momentum across Europe. UEFA EURO 2024™ takes place 14 June-14 July in ten host cities across Germany and will see 24 national teams compete. *Subject to terms and conditions, please check out AliExpress App and website for more details. About AliExpress Launched in 2010, AliExpress (www.aliexpress.com) is a business-to-consumer (B2C) e-commerce platform enabling global consumers to buy directly from manufacturers and distributors in China and around the world. In addition to the global English-language version, the AliExpress platform is also available in 17 other languages. AliExpress is part of Alibaba International Digital Commerce Group.